banner
HCV protease inhibitor BI207127, Purity ≥98%

Cat. No.: X24-06-ZQ976

HCV protease inhibitor BI207127, Purity ≥98%

Synonym: 1221574-24-8; HCV protease inhibitor; Deleobuvir

  • CAS Number: 1221574-24-8
  • Compound CID: 56948249
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BI207127 targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
653.6
Molecular Formula
C34H33BrN6O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BI207127 is a potent inhibition for NS5B RNA-dependent RNA polymerase in Hepatitis C virus (HCV), potentially blocking viral replication.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0